Bioequivalence trials for the approval of generic drugs in Saudi Arabia: a descriptive analysis of design aspects
Althunian, Turki A, Alzenaidy, Bader R, Alroba, Raseel A, Almadani, Ohoud A, Alqahtani, Fahad A, Binajlan, Albatool A, Almousa, Amal I, Alamr, Deema K, Al-Mofada, Malak S, Alsaqer, Nora Y, Alarfaj, Hessa A, Bahlewa, Abdulmohsen A, Alharbi, Mohammed A, Alhomaidan, Ali M, Alsuwyeh, Abdulaziz A, Alsaleh, Abdulmohsen A
Published in BMC medical research methodology (05.04.2024)
Published in BMC medical research methodology (05.04.2024)
Get full text
Journal Article
The association between drug pricing and drug shortage in Saudi Arabia: a retrospective database analysis
Alowairdhi, Mohammad A, Alhussain, Fatimah H, Alomran, Maha I, Almadani, Ohoud A, Alkhammash, Norah A, Alyabes, Shayma F, Alharbi, Sultan A, Almudaiheem, Esraa A, Alhaider, Reem A, Alhassan, Sara A, Almuallem, Zainab A, Algain, Nuha, Alshehri, Abdulaziz O, Alshammari, Thamir M, Althunian, Turki A
Published in Journal of pharmaceutical policy and practice (18.07.2023)
Published in Journal of pharmaceutical policy and practice (18.07.2023)
Get full text
Journal Article
Reflections on the Saudi FDA Regulatory Experience with Smart GxP Inspections
Alhomaidan, Ali M., Al-Murikhi, Nawaf G., Al-Qarni, Morae A., Al Fahaadi, Fahad A., Al Otaibi, Khalid S., Hafiz, Radwan, Almadani, Ohoud A., Al Rafie, Turki A., Al Ageel, Mohammed A., Dahhas, Mohammed A.
Published in Therapeutic innovation & regulatory science (01.07.2024)
Published in Therapeutic innovation & regulatory science (01.07.2024)
Get full text
Journal Article